基本信息
文件名称:RIP1-IN-1-生命科学试剂-MCE.pdf
文件大小:848.69 KB
总页数:3 页
更新时间:2025-05-20
总字数:约6.98千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

RIP1-IN-1

Cat.No.:HY-173185

分?式:C??H??N?O?

分?量:423.46

作?靶点:RIPkinase;Necroptosis

作?通路:Apoptosis

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性RIP1-IN-1是?种?服有效的RIP1抑制剂,具有很强的RIP1结合亲和?(Kd:110nM)。RIP1-IN-1表现出很

强的抗坏死性凋亡(Necroptosis)活性。RIP1-IN-1通过阻断RIP1、RIP3和MLKL信号通路的磷酸化有效抑制

坏死?体的形成。RIP1-IN-1可抑制坏死性凋亡,可?于急性肝损伤的研究。

IC50TargetRIPK1

110nM(Kd)

体外研究RIP1-IN-1(CompoundN-1)(0-1.6μM,5-24h)caneffectivelyanddose-dependentlyinhibitZ-VAD-FMK(HY-

16658B)inducednecroptosisinHT-29cells,aswellasZ-VAD-FMK(HY-16658B)inducednecroptosisin

U937cells[1].

RIP1-IN-1exhibitsstronganti-necroptosisactivityinHT-29cells(CC50:50μMEC50:8.8nM)[1].

RIP1-IN-1(0.4μM,2-6h)effectivelypreventsthephosphorylationofbothRIP1andRIP3inHT-29cells

treatedwithZ-VAD-FMK(HY-16658B)inatime-dependentmanner,therebyinhibitingthephosphorylationof

thedownstreamtargetMLKL[1].

RIP1-IN-1(0.097-400nM,5h)inhibitsRIP1/3andMLKLphosphorylationinadose-responsivemanner[1].